The medical landscape is experiencing a change with the introduction of GLP-1 transdermal systems . These exciting formulations offer a promising approach to providing glucagon-like peptide-1 drugs for individuals managing the disease . Instead of daily shots , a convenient patch placed to the body could administer a steady quantity of the treatmen